Loading...
CDK5 Inhibitor Downregulates Mcl-1 and Sensitizes Pancreatic Cancer Cell Lines to Navitoclax
Developing small molecules that indirectly regulate Mcl-1 function has attracted a lot of attention in recent years. Here, we report the discovery of an aminopyrazole, 2-([1,1′-biphenyl]-4-yl)-N-(5-cyclobutyl-1H-pyrazol-3-yl)acetamide (analog 24), which selectively inhibited cyclin-dependent kinase...
Na minha lista:
| Udgivet i: | Mol Pharmacol |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
The American Society for Pharmacology and Experimental Therapeutics
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6726458/ https://ncbi.nlm.nih.gov/pubmed/31467029 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/mol.119.116855 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|